| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |